Similar articles for PMID: 26243587

Year	Number of Results
2008	2
2009	1
2010	3
2011	11
2012	15
2013	15
2014	18
2015	25
2016	23
2017	25
2018	23
2019	52
2020	81
2021	84
2022	33
2023	16
2024	0

1

Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis.

Goyal SK, Dixit VK, Shukla SK, Ghosh J, Behera M, Tripathi M, Gupta N, Ranjan A, Jain AK. Goyal SK, et al. Indian J Gastroenterol. 2015 Jul;34(4):286-91. doi: 10.1007/s12664-015-0576-1. Epub 2015 Aug 6. Indian J Gastroenterol. 2015. PMID: 26243587

2

Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis.

Köklü S, Tuna Y, Gülşen MT, Demir M, Köksal AŞ, Koçkar MC, Aygün C, Coban S, Ozdil K, Ataseven H, Akin E, Pürnak T, Yüksel I, Ataseven H, Ibiş M, Yildirim B, Nadir I, Küçükazman M, Akbal E, Yüksel O, Başar O, Alkan E, Baykal O. Köklü S, et al. Clin Gastroenterol Hepatol. 2013 Jan;11(1):88-94. doi: 10.1016/j.cgh.2012.10.003. Epub 2012 Oct 9. Clin Gastroenterol Hepatol. 2013. PMID: 23063679

3

Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.

Papatheodoridis GV, Sypsa V, Dalekos G, Yurdaydin C, van Boemmel F, Buti M, Goulis J, Calleja JL, Chi H, Manolakopoulos S, Loglio A, Siakavellas S, Gatselis N, Keskın O, Lehretz M, Savvidou S, de la Revilla J, Hansen BE, Kourikou A, Vlachogiannakos I, Galanis K, Idilman R, Colombo M, Esteban R, Janssen HLA, Berg T, Lampertico P. Papatheodoridis GV, et al. J Hepatol. 2018 Jun;68(6):1129-1136. doi: 10.1016/j.jhep.2018.01.031. Epub 2018 Feb 8. J Hepatol. 2018. PMID: 29427727

4

Comparison of the Efficacy of Entecavir and Tenofovir in Reducing Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients: A Real-Life Study in Turkey.

Güzelbulut F, Gökçen P, Can G, Adalı G, Değirmenci Saltürk AG, Aslan E, Özdil K, Doğanay HL. Güzelbulut F, et al. Turk J Gastroenterol. 2021 Apr;32(4):412-421. doi: 10.5152/tjg.2021.20423. Turk J Gastroenterol. 2021. PMID: 34231488 Free PMC article.

5

Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China.

Yip TC, Wong VW, Chan HL, Tse YK, Lui GC, Wong GL. Yip TC, et al. Gastroenterology. 2020 Jan;158(1):215-225.e6. doi: 10.1053/j.gastro.2019.09.025. Epub 2019 Sep 28. Gastroenterology. 2020. PMID: 31574268

6

Efficacy and safety of entecavir and/or tenofovir in hepatitis B compensated and decompensated cirrhotic patients in clinical practice.

Miquel M, Núñez Ó, Trapero-Marugán M, Díaz-Sánchez A, Jiménez M, Arenas J, Canós AP. Miquel M, et al. Ann Hepatol. 2013 Mar-Apr;12(2):205-12. Ann Hepatol. 2013. PMID: 23396731 Free article.

7

A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea.

Kim SU, Seo YS, Lee HA, Kim MN, Lee YR, Lee HW, Park JY, Kim DY, Ahn SH, Han KH, Hwang SG, Rim KS, Um SH, Tak WY, Kweon YO, Kim BK, Park SY. Kim SU, et al. J Hepatol. 2019 Sep;71(3):456-464. doi: 10.1016/j.jhep.2019.03.028. Epub 2019 Apr 6. J Hepatol. 2019. PMID: 30959156

8

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma.

Riveiro-Barciela M, Tabernero D, Calleja JL, Lens S, Manzano ML, Rodríguez FG, Crespo J, Piqueras B, Pascasio JM, Comas C, Gutierrez ML, Aguirre A, Suárez E, García-Samaniego J, Rivero M, Acero D, Fernandez-Bermejo M, Moreno D, Sánchez-Pobre P, de Cuenca B, Moreno-Palomares JJ, Esteban R, Buti M. Riveiro-Barciela M, et al. Dig Dis Sci. 2017 Mar;62(3):784-793. doi: 10.1007/s10620-017-4448-7. Epub 2017 Jan 11. Dig Dis Sci. 2017. PMID: 28078526

9

Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review.

Tseng CH, Tseng CM, Wu JL, Hsu YC, El-Serag HB. Tseng CH, et al. J Gastroenterol Hepatol. 2020 Oct;35(10):1684-1693. doi: 10.1111/jgh.15078. Epub 2020 May 17. J Gastroenterol Hepatol. 2020. PMID: 32343431

10

Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs).

Grossi G, Viganò M, Loglio A, Lampertico P. Grossi G, et al. Liver Int. 2017 Jan;37 Suppl 1:45-51. doi: 10.1111/liv.13291. Liver Int. 2017. PMID: 28052621 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

360 results

Results by year